Stem Cell Therapy Market Overview, Size, Share | Global Industry Outlook and Statistics, Segmentation and Forecast
Market Size – USD 342.7 million in 2019, Market Growth – CAGR of 36.2%, Market Trends – Technological Advancement.
— Emerging research
VANCOUVER, BC, CANADA, June 21, 2022 /EINPresswire.com/ — The global stem cell therapy market is expected to reach USD 3,693.6 million by 2027, according to a new report from Emergen Research . The stem cell therapy market is witnessing an increased demand owing to the increase in the number of clinical trials all over the world. Stem cells are applicable to the development of regenerative medicine, commonly used in the field of dermatology. However, the demand for stem cell applications in the oncology segment will witness the greatest growth owing to several pipeline projects present for the treatment of cancer or tumors. The development of advanced genomic analysis techniques, the introduction of effective guidelines for the manufacture of cell therapy, a large amount of research by cancer companies and the proven efficacy of transplants are some of the major growth stimulators for the market. Certain manufacturing and pharmacological issues and regulatory hurdles are hampering the growth of the market.
Current COVID-19 pandemic is expected to impact Stem Cell Therapy industry growth primarily due to movement restrictions and impact on supply & demand due to lockdowns. COVID-19 pandemic has affected several sectors of the global market and the Stem Cell Therapy sector is expected to feel the impact of the pandemic. The global stem cell therapy market report initially offers an in-depth overview of the stem cell therapy market along with insights into developments and advancements in the industry. The report offers a comprehensive overview of the regional and competitive landscape and provides a deeper insight into the current market scenario and future growth prospects. The research study also provides a comprehensive analysis of the market drivers, restraints, limitations, threats, risks, and growth opportunities.
Click the link for a free sample copy of the report: @https://www.emergenresearch.com/request-sample/83
Some highlights of the report
Allogeneic stem cell therapy led the stem cell therapy segment by type. Allogeneic transplantation is recommended for patients who are at high risk of relapse even after successful treatment with chemotherapy. An increase in the frequency of cancer relapses propelled demand for the segment. The segment has an added advantage as it manufactures its own immune stem cells. These cells have the potential to kill cancer cells that remain after high dose treatment with cytotoxic drugs.
Improved state-of-the-art orthopedic treatments involving stem cell therapy have contributed to pain relief and also recovery time. It eliminates the need for medications and invasive surgery, such as joint replacements, which increases mobility. The regenerative medicine segment is expected to grow with a CAGR of 36.4% during the forecast period.
The hospital held a larger market share due to the growing preference for stem cell therapies in these institutions. Hospitals are affiliated with academic institutes and research laboratories for the development of new therapies. Hospitals are implementing the latest findings.
North America will account for the largest share of the global stem cell market. The major contribution will come from the United States, and the region will experience strong growth due to increased funding from private and government companies for clinical trials.
The report highlights the current impact of COVID-19 on the Stem Cell Therapy market along with the latest economic scenario and changing market dynamics. It analyzes the impact of the pandemic on market growth and compensation. The pandemic has changed the economic scenario of the world and affected several market sectors. The report estimates the stem cell therapy market based on the impact of COVID-19.
Key Players/Manufacturers profiled in the report are:
Virgin Health Bank, Celgene Corporation, ReNeuron Group plc, Biovault Family, Precious Cells International Ltd., Mesoblast Ltd., Opexa Therapeutics, Inc., Caladrius, Neuralstem, Inc. and Pluristem, among others.
Request Report Discount @https://www.emergenresearch.com/request-discount/83
For the purposes of this report, Emergen Research has segmented the global stem cell therapy market on the basis of type, application, end-user, and region:
Type Outlook (Revenue, USD Million; 2017-2027)
Allogeneic Stem Cell Therapy
Autologous stem cell therapy
Application Outlook (Revenue, USD Million; 2017-2027)
Hematological stem cells
Soft tissue injuries
Cardiovascular and myocardial infarction
Drug discovery and development
End User Outlook (Revenue, USD Million; 2017-2027)
Regional Analysis For Stem Cell Therapy Market Includes:
North America (USA, Canada)
Europe (UK, Italy, Germany, France, Rest of EU)
Asia-Pacific (India, Japan, China, South Korea, Australia, rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa, Rest of MEA)
The report offers comprehensive understanding of Stem Cell Therapy market in key regions with respect to regional production & consumption patterns, import/export, supply & demand dynamics, trends, growth prospects and the presence of leading players in each region. Each of the mentioned regions is analyzed based on the comprehensive market data obtained from the major countries in each region to give a clear understanding of the market.
Request Report Customization @https://www.emergenresearch.com/request-for-customization/83
The report offers insightful insights into market dynamics of the Stem Cell Therapy Market. It offers SWOT analysis, PESTEL analysis, and Porter’s Five Forces analysis to present a better understanding of the Stem Cell Therapy market, competitive landscape, factors affecting it, and to predict the growth of the industry. . It also offers the impact of various market factors along with the effects of regulatory framework on the growth of the Stem Cell Therapy market.
Key Coverage of Stem Cell Therapy Market:
Relevant insights into the global stem cell therapy market
Identifying growth in various segments and sub-segments of the Stem Cell Therapy Market
Strategic recommendations for investment opportunities
The report covers important industry related statistics along with products, applications, price analysis, demand and supply, and rate of production and consumption
Emerging trends and analysis of current market segments to help investors formulate new business strategies
Accelerates the decision-making process thanks to the availability of pilots and constraints
Click here to continue now @ https://www.emergenresearch.com/select-license/83
Thank you for reading our report. To request customization or for more information, please contact us. Our team will ensure that the report is tailored to your needs.
Read similar reports by Emergen Research:
Web 3.0 market
Ultrafiltration Membrane Market
Smart Retail Market
Agricultural robotics market
home security systems market
About Emergen Research
Emergen Research is a market research and consulting firm that provides syndicated research reports, custom research reports, and consulting services. Our solutions are uniquely focused on your goal to locate, target and analyze changes in consumer behavior across demographics, across industries, and help customers make smarter business decisions. We offer market intelligence research ensuring relevant and factual research across multiple sectors including health, touchpoints, chemicals, types and energy. We are constantly updating our search offerings to ensure that our clients are aware of the latest trends existing in the market. Emergen Research has a strong base of experienced analysts from a variety of areas of expertise. Our industry experience and ability to develop a workable solution to any research problem gives our clients the ability to secure an edge over their respective competitors.
Stem cell therapy market size worth USD 3,693.6 million by 2027